Prefer the standard once-weekly injection
Snaith JR, Holmes-Walker DJ, Greenfield JR (2020) Reducing type 1 diabetes mortality: role for adjunctive therapies
Like Wegovy, Zepbound is FDA-approved for weight management in adults with obesity (BMI of 30 or higher) or overweight (BMI of 27 or higher) and related health issues like high blood pressure or diabetes
10.1073/pnas.2506321122 32 TaoZ.Le Blanc JustinM.WangC.ZhanT.ZhuangH.WangP.et al (2016)
Noninvasive routes do not inherently improve pharmacodynamic precision, therapeutic index, or safety relative to parenteral administration, and conflating convenience with clinical benefit risks obscuring the biological constraints that govern treatment success
para control de peso, la dosis objetivo tpica es 10-15 mg semanales, aunque algunos pacientes pueden beneficiarse de dosis menores